ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan sets safety standards for iPS cell transplants

TOKYO -- The Japanese health ministry has drawn up guidelines for determining the safety of laboratory-created stem cell treatments in clinical trials, a step that could pave the way for more such studies.

The standards, approved Friday, will be used to evaluate trials that involve transplanting induced pluripotent stem cells -- adult cells reprogrammed to a state similar to embryonic cells -- into the human body.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more